In summary, we generated a de novo KI mouse model to demonstrate LINK‐A to be an effective RNA‐based therapeutic drug target to treat HFD‐induced obesity, evidenced by the nucleic acid drug ASO preventing the developing HFD‐induced obesity in LINK‐A KI mice. The gene discussed is LINC01139; the disease is Obesity.